Integrated needle-free injection and sensing using opto-microfluidics

iSENS is developing BoldJet, a portable needle-free injector using thermocavitation microjets for precise, safe, and environmentally friendly medication delivery, enhancing patient compliance and healthcare outcomes.

Subsidie
€ 2.499.999
2024

Projectdetails

Introduction

Needle-based injections have revolutionised healthcare by providing an efficient delivery method for medications, such as vaccines. However, there are significant drawbacks associated with using needles on a societal, environmental, and technological level.

Challenges of Needle Use

Needle phobia and infection risks can significantly impact patient compliance and safety with medical treatments. Additionally, millions of used needles contaminate the environment every day. Lastly, the effectiveness of certain drugs increases when injected intradermally, but targeting the dermis is challenging.

Project Overview

With iSENS, we want to revolutionise the experience of people who receive and perform frequent injections. To this end, we are developing and commercialising a portable and needle-free injector called BoldJet. Our technological breakthrough is threefold:

  1. Needle-Free Injection Breakthrough: We introduce an innovative needle-free injection technology, globally pioneering the use of thermocavitation microjets. Our system excels in the precise and consistent delivery of liquids into the skin's superficial layers, surpassing current state-of-the-art methods.

  2. Smart Sensing Capability: The BoldJet device will incorporate cutting-edge sensing technology, enabling it to assess the unique properties of the patient's skin before each injection. This breakthrough allows for semi-automatic calibration, tailoring the injection parameters to the specific skin type and treatment area.

  3. Real-Time Monitoring and Precision: BoldJet goes beyond conventional methods by offering real-time monitoring of injection depth and volume. This feature guarantees that each dose is administered accurately and consistently.

Conclusion

With our triple technology platform, we will offer safer, more effective, and minimally invasive injections that do not contaminate our environment. This patient-friendly technology will result in a positive effect on society, allowing millions of people to receive better and more personalised healthcare.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.499.999
Totale projectbegroting€ 2.512.500

Tijdlijn

Startdatum1-7-2024
Einddatum30-6-2027
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • FLOWBEAMS BVpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen EIC Transition

EIC Transition

Fully automated cell-free DNA extraction and quantification - liquid biopsies safely from Patient to Lab

BiopSense aims to develop and validate a fully automated disposable cartridge for cfDNA extraction from blood, enhancing reliability and transport ease for cancer diagnostics and prenatal screening.

€ 2.500.000
EIC Transition

MICRO-MECHANICAL PUMP FOR NEXT GENERATION INSULIN DELIVERY SYSTEMS

PRISMA aims to validate a novel, ultra-compact micropump for wearable insulin delivery, enhancing accuracy and efficiency to revolutionize diabetes treatment and enable multi-drug systems.

€ 2.499.838

Vergelijkbare projecten uit andere regelingen

ERC Proof of...

Skin micro-injector

Bold-Jet aims to revolutionize needle-free injections with a microjet device that enhances safety, minimizes invasiveness, and improves patient adherence to treatments.

€ 150.000
ERC Proof of...

Overcoming limits for pre-clinical small volume liquid delivery into skin and inflammation quantification

This project aims to validate the BuBble Gun injection method using Skin-On-Chip technology for localized drug testing in chronic skin diseases, paving the way for innovative treatment delivery.

€ 150.000
Mkb-innovati...

Dermaal microinjectie systeem met holle micronaalden voor oa vaccinaties

Dit project onderzoekt de haalbaarheid van een pijnloos micro-injectiesysteem voor nauwkeurige medicatietoediening, met potentieel voor kankervaccinaties en verbeterde vaccinatiecapaciteit.

€ 20.000
Mkb-innovati...

Epinefrine Auto Injector innovation

Dit project onderzoekt een innovatieve, patiënt-specifieke Epinefrine Auto-Injector pen om de effectiviteit en toegankelijkheid van anafylaxiebehandeling te verbeteren.

€ 20.000
Mkb-innovati...

NEW PRODUCTION METHOD OF INJECTABLE MICROCAPSULES FOR PULSATILE VACCINE DELIVERY

IamFluidics onderzoekt de haalbaarheid van 'in-air microfluidics' voor het produceren van polylactic acid microcapsules voor gecontroleerde vaccinafgifte, met als doel een kosteneffectieve, pulsatile injectieoplossing.

€ 20.000